
Researchers used the IonOptix MyoStretcher and MultiCell to show that inhibiting RBM20 reduces titin stiffness and improves diastolic function. Inducing compliant titin isoforms offers a novel therapeutic strategy for HFpEF. 🫀 Full study: shorturl.at/hj8T8

















